Cargando…
Decreased Hyocholic Acid and Lysophosphatidylcholine Induce Elevated Blood Glucose in a Transgenic Porcine Model of Metabolic Disease
(1) Background: This work aims to investigate the metabolomic changes in PIGinH11 pigs and investigate differential compounds as potential therapeutic targets for metabolic diseases. (2) Methods: PIGinH11 pigs were established with a CRISPR/Cas9 system. PNPLA3(I148M), hIAPP, and GIPR(dn) were knocke...
Autores principales: | Xu, Jianping, Zhang, Kaiyi, Qiu, Bintao, Liu, Jieying, Liu, Xiaoyu, Yang, Shulin, Xiao, Xinhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784658/ https://www.ncbi.nlm.nih.gov/pubmed/36557202 http://dx.doi.org/10.3390/metabo12121164 |
Ejemplares similares
-
Hyocholic acid and glycemic regulation: comments on ‘Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism’
por: Jia, Wei, et al.
Publicado: (2021) -
Hyocholic acid species as novel biomarkers for metabolic disorders
por: Zheng, Xiaojiao, et al.
Publicado: (2021) -
An Integrated Metabolomic Study of Osteoporosis: Discovery and Quantification of Hyocholic Acids as Candidate Markers
por: Deng, Dawei, et al.
Publicado: (2021) -
Elevated 18:0 lysophosphatidylcholine contributes to the development of pain in tissue injury
por: Friston, Dominic Anthony, et al.
Publicado: (2023) -
Bioactive Lysophosphatidylcholine 16:0 and 18:0 Are Elevated in Lungs of Asthmatic Subjects
por: Yoder, Mark, et al.
Publicado: (2014)